Biomea Fusion Inc (BMEA)

Biomea Fusion Inc (BMEA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $50M; returns 1 day +2.6%, 1 week -30.9%, 1 year -56.5%.

Biomea Fusion Inc. (BMEA) is a clinical-stage biopharmaceutical company primarily focused on discovering and developing oral covalent small molecule therapies for metabolic diseases, specifically diabetes and obesity. The company generates no product revenue currently, operating through financing activities such as equity raises.

Groups BMEA belongs to

• Healthcare
• Biotechnology
• Clinical Stage Biotech
• Metabolic Disorders
• Biopharmaceutical
• Type 1 Diabetes
• GLP-1 Agonists
• Weight Management
• Endocrinology
• Life Sciences
• Clinical Stage

BMEA financial model: income statement, cash flow and balance sheet